Ure Atik, Altrup Ulrich
Institute of Experimental Epilepsy Research, University of Münster, Hüfferstrabe 68, Germany.
Neurosci Lett. 2006 Jan 9;392(1-2):10-5. doi: 10.1016/j.neulet.2005.08.045. Epub 2005 Sep 19.
Effects of cAMP-activated protein kinases (PKA) on epileptic activity are at present studied in a model nervous system. Identified neurons in the buccal ganglia of the snail Helix pomatia were recorded with intracellular microelectrodes in a continuously perfused experimental chamber. Epileptiform activity appeared regularly in neuron B3 when the saline contained pentylenetetrazol (20-40 mM). Epileptiform activity consisted of a series of paroxysmal depolarization shifts (PDS). Epileptiform activity was quantified by calculating the percentage of PDS-duration of PDS-periods. High percentage of PDS-duration was regularly found 15-30 min after the start of treatment with pentylenetetrazol. Subsequently, percentage of PDS decreased spontaneously. Adding forskolin (50 microM) to the pentylenetetrazol-containing solution increased percentage of PDS-duration. The increase during forskolin corresponded to the amount of decrease which had taken place spontaneously before. During application of forskolin for up to 4 h, spontaneous PDS decrease was absent, i.e., epileptiform activity corresponded to status epilepticus. Forskolin was not able to induce epileptiform activity when applied without pentylenetetrazol. 1,6-Dideoxy-forskolin (50 microM) did not accelerate epileptiform activity. When pentylenetetrazol was applied twice (1 h each) separated by 2.5 h of control conditions, PDS decrease obtained during the first application was found to be largely preserved during control conditions. When forskolin was applied for 30 min in between both applications of pentylenetetrazol, the second response to pentylenetetrazol did not show a preserved PDS decrease. Results suggest that forskolin blocks an endogenous antiepileptic process and that activation of PKA can maintain epileptic activity and induce status epilepticus.
目前正在一个模型神经系统中研究环磷酸腺苷(cAMP)激活的蛋白激酶(PKA)对癫痫活动的影响。在一个持续灌注的实验室内,用细胞内微电极记录蜗牛葡萄状螺旋体颊神经节中已识别的神经元。当盐溶液中含有戊四氮(20 - 40 mM)时,神经元B3会定期出现癫痫样活动。癫痫样活动由一系列阵发性去极化偏移(PDS)组成。通过计算PDS持续时间在PDS发作期所占的百分比来量化癫痫样活动。在开始使用戊四氮治疗15 - 30分钟后,经常会发现PDS持续时间的高百分比。随后,PDS的百分比会自发下降。向含戊四氮的溶液中添加福司可林(50 microM)会增加PDS持续时间的百分比。福司可林作用期间的增加量与之前自发发生的减少量相当。在应用福司可林长达4小时的过程中,未出现自发的PDS减少,即癫痫样活动相当于癫痫持续状态。在没有戊四氮的情况下应用福司可林不能诱导癫痫样活动。1,6 - 二脱氧 - 福司可林(50 microM)不会加速癫痫样活动。当戊四氮分两次应用(每次1小时),中间间隔2.5小时的对照条件时,发现在第一次应用期间获得的PDS减少在对照条件下基本保持。当在两次戊四氮应用之间应用福司可林30分钟时,对戊四氮的第二次反应未显示出PDS减少的保持。结果表明,福司可林阻断了内源性抗癫痫过程,并且PKA的激活可以维持癫痫活动并诱导癫痫持续状态。